What shareholders can do to beat the market with Magenta Therapeutics Inc. (MGTA) stock

In the latest session, Magenta Therapeutics Inc. (NASDAQ: MGTA) closed at $1.16 down -1.69% from its previous closing price of $1.18. In other words, the price has decreased by -$0.0200 from its previous closing price. On the day, 166271 shares were traded. MGTA stock price reached its highest trading level at $1.2200 during the session, while it also had its lowest trading level at $1.1000.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Ratios:

For a deeper understanding of Magenta Therapeutics Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.20 and its Current Ratio is at 10.20. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

On January 06, 2022, Goldman Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $7 to $8.

Stock Price History:

Over the past 52 weeks, MGTA has reached a high of $6.73, while it has fallen to a 52-week low of $0.92. The 50-Day Moving Average of the stock is 1.3300, while the 200-Day Moving Average is calculated to be 1.8233.

Shares Statistics:

For the past three months, MGTA has traded an average of 164.69K shares per day and 218.2k over the past ten days. A total of 59.27M shares are outstanding, with a floating share count of 55.86M. Insiders hold about 0.60% of the company’s shares, while institutions hold 71.40% stake in the company. Shares short for MGTA as of Oct 13, 2022 were 417.16k with a Short Ratio of 0.41M, compared to 458.78k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.71% and a Short% of Float of 0.89%.

Earnings Estimates

There are 5 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.3 for the current quarter, with a high estimate of -$0.27 and a low estimate of -$0.32, while EPS last year was -$0.3. The consensus estimate for the next quarter is -$0.29, with high estimates of -$0.23 and low estimates of -$0.34.

Analysts are recommending an EPS of between -$1.19 and -$1.34 for the fiscal current year, implying an average EPS of -$1.27. EPS for the following year is -$0.93, with 5 analysts recommending between -$0.3 and -$1.29.